Percutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis.
Kevane, B Ryder, D Q Gilligan, O
Kevane, B
Ryder, D Q
Gilligan, O
Author
Advisors
Editors
Other Contributors
Date
2012-01-09T15:47:31Z
Date Submitted
Keywords
Other Subjects
Subject Mesh
Aged
Cohort Studies
Female
Fractures, Bone
Histiocytosis, Langerhans-Cell
Humans
Male
Multiple Myeloma
Osteoporosis
Questionnaires
Retrospective Studies
Treatment Outcome
Vertebroplasty
Cohort Studies
Female
Fractures, Bone
Histiocytosis, Langerhans-Cell
Humans
Male
Multiple Myeloma
Osteoporosis
Questionnaires
Retrospective Studies
Treatment Outcome
Vertebroplasty
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
This review aims to assess the effectiveness of percutaneous vertebroplasty as a treatment for the severe refractory pain associated with vertebral fracture, in a group of patients with fractures secondary to either osteoporotic or neoplastic disease. A retrospective review of 20 patients treated with percutaneous vertebroplasty in Cork University Hospital up until March 2007 was carried out and a questionnaire was prepared and distributed. Prior to vertebroplasty, patients had been symptomatic with severe pain for a mean of 20.9 weeks. Of those thirteen whom replied to a postal questionnaire, 12 (92.3%) reported pain relief and this improvement occurred within 7 days in 9 (81.8%). This was associated with decreased analgesic requirements, as determined on chart review. Prior to the procedure only 5 (38.4%) were independently mobile and this figure rose to 10 (76.9%) afterwards, occurring within one week in the majority. Subjective outcomes were better in the group of patients with neoplasm-induced fractures.
Language
en
ISSN
0332-3102
eISSN
ISBN
DOI
PMID
19772001